BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34506676)

  • 21. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
    Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
    Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
    Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes following stereotactic radiosurgery or whole brain radiation therapy by molecular subtype of metastatic breast cancer.
    Haque W; Verma V; Adeberg S; Rustomily R; Lo S; Butler EB; Teh BS
    Rep Pract Oncol Radiother; 2021; 26(3):341-351. PubMed ID: 34277087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients.
    Fokas E; Henzel M; Hamm K; Surber G; Kleinert G; Engenhart-Cabillic R
    Strahlenther Onkol; 2010 Apr; 186(4):210-7. PubMed ID: 20165820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases.
    Cagney DN; Lamba N; Montoya S; Li P; Besse L; Martin AM; Brigell RH; Catalano PJ; Brown PD; Leone JP; Tanguturi SK; Haas-Kogan DA; Alexander BM; Lin NU; Aizer AA
    Breast Cancer Res Treat; 2019 Jul; 176(1):171-179. PubMed ID: 30982195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
    El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
    Front Oncol; 2020; 10():693. PubMed ID: 32477942
    [No Abstract]   [Full Text] [Related]  

  • 27. Gamma Knife radiosurgery for brain metastases from primary breast cancer.
    Kased N; Binder DK; McDermott MW; Nakamura JL; Huang K; Berger MS; Wara WM; Sneed PK
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1132-40. PubMed ID: 19345514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases.
    Yomo S; Hayashi M
    J Neurooncol; 2013 Jul; 113(3):459-65. PubMed ID: 23661101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of radiotherapy in breast cancer patients with brain metastases: a retrospective 11-year single center study.
    Gullhaug A; Hjermstad MJ; Yri O; Svestad JG; Aass N; Johansen S
    J Med Imaging Radiat Sci; 2021 Jun; 52(2):214-222. PubMed ID: 33549504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases.
    Khatri VM; Mills MN; Oliver DE; Yu HM; Vogelbaum MA; Forsyth PA; Soliman HH; Han HS; Ahmed KA
    J Neurooncol; 2023 Aug; 164(1):191-197. PubMed ID: 37490232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain Metastases.
    Gorovets D; Ayala-Peacock D; Tybor DJ; Rava P; Ebner D; Cielo D; Norén G; Wazer DE; Chan M; Hepel JT
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):246-253. PubMed ID: 28068233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer.
    Borm KJ; Behzadi ST; Hörner-Rieber J; Krug D; Baumann R; Corradini S; Duma MN; Dunst J; Fastner G; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Matuschek C; Piroth MD; Schmeel LC; Souchon R; Strnad V; Budach W; Combs SE;
    Strahlenther Onkol; 2024 Apr; 200(4):259-275. PubMed ID: 38488902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of stereotactic radiosurgery for brain metastases from breast cancer: who benefits most?
    Cho E; Rubinstein L; Stevenson P; Gooley T; Philips M; Halasz LM; Gensheimer MF; Linden HM; Rockhill JK; Gadi VK
    Breast Cancer Res Treat; 2015 Feb; 149(3):743-9. PubMed ID: 25638395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer.
    Id Said B; Soliman H; Moravan V; Myrehaug S; Tseng CL; Detsky J; Sahgal A; Warner E; Jerzak KJ
    J Neurooncol; 2023 Sep; 164(2):437-445. PubMed ID: 37634217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic Therapies.
    Mashiach E; Alzate JD; De Nigris Vasconcellos F; Bernstein K; Donahue BR; Schnurman Z; Gurewitz J; Rotman LE; Adams S; Meyers M; Oratz R; Novik Y; Kwa MJ; Silverman JS; Sulman EP; Golfinos JG; Kondziolka D
    Neurosurgery; 2024 Jan; 94(1):154-164. PubMed ID: 37581437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Treatments and Disease Course for Women with Breast Cancer Brain Metastases: 5-Year Retrospective Single Institution Experience.
    Chew S; Carroll HK; Darwish W; Boychak O; Higgins M; McCaffrey J; Kelly CM
    Cancer Manag Res; 2021; 13():8191-8198. PubMed ID: 34754239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The breast graded prognostic assessment is associated with the survival outcomes in breast cancer patients receiving whole brain re-irradiation.
    Lai SF; Chen YH; Liang TH; Hsu CY; Lien HC; Lu YS; Huang CS; Kuo SH
    J Neurooncol; 2018 Jul; 138(3):637-647. PubMed ID: 29557535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Karnofsky Performance Status (KPS) ≤60 Is Strongly Associated With Shorter Brain-Specific Progression-Free Survival Among Patients With Metastatic Breast Cancer With Brain Metastases.
    Freeman M; Ennis M; Jerzak KJ
    Front Oncol; 2022; 12():867462. PubMed ID: 35965535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follow-up results of brain metastasis patients undergoing repeat Gamma Knife radiosurgery.
    Koiso T; Yamamoto M; Kawabe T; Watanabe S; Sato Y; Higuchi Y; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2016 Dec; 125(Suppl 1):2-10. PubMed ID: 27903177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.